Telegraph Hill Partners
Venture capitalSan Francisco · Growth–Late Stage · 19 people tracked
Also known as TELEGRAPH HILL PARTNERS MANAGEMENT COMPANY LLC
Investment thesis
Telegraph Hill Partners partners with private life science, medical device, and healthcare companies that have novel technologies, a solid customer base, and innovative management teams. The firm provides growth capital to high-quality companies seeking to build and expand their organizations, offering an experienced team focused on efficiently driving growth and profitability while preserving each company's vision and integrity.
Source: firm website, verified Aug 11, 2026.
Team · 19 people
from the firm's website & public directories
What they invest in
from 24 of 29 portfolio companiesBiotech ×15Healthtech ×9Deep Tech ×7Medical Devices ×6AI & Machine Learning ×5Advanced Manufacturing ×4Enterprise Software ×3SaaS ×3
HQs:United States×19
Investments · 29 tracked
founders shown can be your intro pathBy year:2023 · 32022 · 12021 · 22019 · 22017 · 32016 · 12015 · 113 dated
etherFAX provides cloud-based secure document delivery and fax transmission for businesses handling sensitive information.
AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareHealthtechSaaS
Paul Banco(Co-Founder and EVP of Federal Programs)Rob Cichielo(Co-Founder and Chief Technology Officer)Jay Volk(Chief Executive Officer)Emil Sturniolo(Chief Security Officer)Allison Kirsch(Chief Marketing Officer)
San Francisco, US
Garry Nolan(Director)Thomas Raffin(Director)Matthew Winkler(Director)Brian McKelligon(Executive Officer)
BoardRob Hart(Executive Officer)
Board seatRobert Shepler· per SEC Form D · $9M raise · filed Jul 2017
BiotechAnn Arbor, US
Thomas Raffin(Director)Alberto Elli(Executive Officer, Director)Jack Ball(Executive Officer, Director)
Board seatDeval LashkariRob Hart· per SEC Form D · $9.8M raise · filed Jun 2017
HealthtechCarlsbad, US
ALEXANDER HERZICK(Director)RICK HANCOCK(Director)WAYNE WOODARD(Executive Officer, Director)
Board seatDeval LashkariPaul Grossman· per SEC Form D · $10.3M raise · filed Apr 2016
Cell Microsystems develops integrated platforms for cell engineering, isolation, culture, and analysis.
BiotechDeep TechMedical DevicesDurham, US
Nancy Allbritton(Director)Yuli Wang(Director)Matthew Megaro(Director)Gary Pace(Executive Officer, Director)Christopher Sims(Executive Officer, Director)
Board seatDeval LashkariRob Capone· per SEC Form D
BiotechSan Diego, US
Robert Finzi(Director)David Wellis, Ph.D.(Executive Officer, Director)Alex Herzik(Director)
Board seatDeval LashkariPaul Grossman· per SEC Form D · $15M raise · filed Nov 2021
HealthtechBloomington, US
Steve Lefar(Director)David McLean(Executive Officer, Director)Ravi Nalliah(Director)Kevin Roche(Executive Officer, Director)
BoardJeanette Welsh(Director)J. Matthew Mackowski(Director)
Board seatRob CaponeGary Curtis· per SEC Form D · filed Dec 2022
Invisalert Solutions provides a patient safety platform using machine learning and AI to monitor and prevent adverse events such as falls, infections, and elopement across acute care, emergency departments, behavioral health, and long-term care facilities.
AI & Machine LearningEnterprise SoftwareHealthtechWest Chester, US
Pete Nagy(Executive Officer, Director)Regina Widdow(Director)Lu Castillo(Director)Michael O'Gorman(Director)Michelle Marcoglongo(Director)Mark Gold(Director)
Board seatRob HartGary CurtisTom Raffin· per SEC Form D
Mosaic Biosciences is an integrated biologics discovery partner offering antibody discovery, protein engineering, and translational pharmacology services to advance complex antibody and protein therapeutics from concept to candidate selection.
BiotechDeep TechBoulder, US
Eric Furfine(Chief Scientific Officer)Alexei Kazantsev(Vice President Protein Design and Engineering)Tracey Mullen(Chief Strategy Officer)Scott Glaser(SVP, Biologics Discovery)Dan Mitchell(Director)Martin Stanton(Executive Officer, Director)
Board seatJeanette WelshRob Capone· per SEC Form D
BiotechMadison, US
Jigar Patel(Executive Officer, Director)
Board seatDeval LashkariRob Hart· per SEC Form D
Panome Bio provides multi-omics discovery services using mass spectrometry-based metabolomics and proteomics to identify biomarkers and generate mechanistic insights for research institutions and pharmaceutical companies.
AI & Machine LearningBiotechDeep TechSaint Louis, US
Alexander Herzick(Director)Edward Weinstein(Executive Officer, Director)Tom Cohen(Executive Officer)
BoardDavid Smoller(Director)
Board seatDeval LashkariRob Capone· per SEC Form D
BiotechVancouver
Andrew Booth(Director)Andrew J. Schwab(Director)R. James Taylor(Executive Officer, Director)Joe Victor(Executive Officer, Director)Euan Ramsay(Executive Officer)Daniel Nixon(Director)
Board seatDeval Lashkari· per SEC Form D · $6M raise · filed Nov 2019
Seattle, US
Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)
Board seatRobert Shepler· per SEC Form D · $16.3M raise · filed Aug 2017
Argonaut Manufacturing Solutions develops software for biopharmaceutical manufacturing operations, focusing on fill-finish processes and yield optimization.
Advanced ManufacturingBiotechSaaS
Carterra develops surface plasmon resonance (SPR) platforms for high-throughput biomolecular interaction analysis.
BiotechDeep TechMedical Devices
DYNEX Technologies manufactures fully automated ELISA laboratory systems and diagnostic instruments for clinical and research laboratories.
Medical Devices
Emerging Therapy Solutions provides comprehensive management solutions for cell and gene therapies and transplants to payers, self-insured employers, and secondary payers.
HealthtechInsurTechMedical Devices
David J. McLean
Frontier Psychiatry provides telepsychiatry services for residents of Montana, Idaho, and Alaska, offering psychiatric evaluations, medication management, therapy, and ADHD assessments without requiring referrals.
Digital HealthHealthtechMental HealthMontana, US
Montana psychiatrists
MIT spin-out offering a customizable multi-solution platform for discovery, development, and manufacturing of cell therapies using non-viral delivery technology.
BiotechCambridge, US
Cullen Buie(Director)Michael Chiu(Director, Executive Officer)Paulo Garcia(Executive Officer, Director, Promoter)
BoardPaxton Major(Director)Ann DeWitt(Director)Paul Wotton(Director)
Nivagen is a specialty pharmaceutical company that develops, manufactures, and markets generic and specialty drugs including sterile injectables and 505(b)(2) products, operating manufacturing facilities in California, Europe, and Japan.
Advanced ManufacturingBiotechHealthtechCalifornia, US
Promptly provides an all-in-one patient experience suite that automates administrative tasks like appointment scheduling, reminders, and payment processing for medical practices.
Enterprise SoftwareHealthtechSaaS
RevMedica develops smart surgical stapling and soft tissue management systems for minimally invasive and robotic procedures, designed to provide real-time intraoperative data and improve clinical decision-making for surgeons.
AI & Machine LearningHealthtechMedical DevicesMiddletown, US
Thomas Wenchell(Chief Executive Officer and Co-Founder)inC. Robert Satti(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Feb 2016
Disclosed stake · filed Jan 2015
Disclosed stake · filed Feb 2014
7 insider ownership filings (Forms 3/4/5)
at Alpha Teknova, Inc. (TKNO)
Files 13F institutional holdings reports · latest Jan 2016
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- What stage does Telegraph Hill Partners invest at?
- Telegraph Hill Partners invests at the Growth, Late Stage stages.
- What is Telegraph Hill Partners's typical check size?
- Telegraph Hill Partners typically writes checks of $2M – $8M.
- What sectors does Telegraph Hill Partners focus on?
- Telegraph Hill Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Telegraph Hill Partners located?
- Telegraph Hill Partners is headquartered in San Francisco, US.
- Does Telegraph Hill Partners lead rounds?
- Yes, Telegraph Hill Partners leads investment rounds.
Images
Co-investors · 1
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Firms observed investing alongside Telegraph Hill Partners, from public investor directories. Shared companies are the overlap with Telegraph Hill Partners's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.